Literature DB >> 10653006

Teratomatous genotype detected in malignancies of a non-germ cell phenotype.

M Devouassoux-Shisheboran1, A O Vortmeyer, S A Silver, Z Zhuang, F A Tavassoli.   

Abstract

Originating from post-meiotic germ cells, mature ovarian teratomas (MOT) are genetically homozygous tumors within heterozygous hosts. MOT may be associated with malignant tumors of a non-germ cell phenotype (so-called malignant transformation). Based on the presence of in situ changes, some cases have been hypothesized to arise from teratomatous tissue. However, other malignancies associated with mature teratomas, such as sarcomas, may originate from either teratomatous elements or preexisting somatic ovarian tissue. Eight cases of MOT containing various histologic types of malignancy, including four squamous cell carcinomas, two sarcomas, one thyroid carcinoma, and one carcinoid tumor, were selected for study. Using selective tissue microdissection and PCR-based analysis of the extracted DNA, we compared the genotypic pattern of the mature teratomatous components to the associated malignant neoplasm with a random panel of highly informative genetic markers for different chromosomes. In all eight cases, genetic analysis of the malignant component revealed a homozygous genotype. In seven cases, the genetic profiles of mature teratomas and the associated malignant tumors were identical, suggesting a direct pathogenetic relationship between these lesions. In one case, the malignant component revealed homozygosity of different alleles compared with mature teratoma, suggesting independent teratomatous growth processes. This finding indicates that some ovarian malignancies of the non-germ cell phenotype arise in teratoma and fall into the spectrum of germ cell tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10653006     DOI: 10.1038/labinvest.3780011

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Recurrent small bowel obstruction in an elderly woman.

Authors:  T S Chandrasekar; M Murugesh; M Murthy; B S Ramakrishna
Journal:  Indian J Gastroenterol       Date:  2010-03

2.  Glial implants in gliomatosis peritonei arise from normal tissue, not from the associated teratoma.

Authors:  A W Ferguson; H Katabuchi; B M Ronnett; K R Cho
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Genetic zygosity of mature ovarian teratomas, struma ovarii, and ovarian carcinoids.

Authors:  Noriko Kato; Kazuhiro Sakamoto; Koutaro Murakami; Yuri Iwasaki; Akihisa Kamataki; Akira Kurose
Journal:  Virchows Arch       Date:  2018-02-17       Impact factor: 4.064

4.  Angiosarcoma originating from an ovarian mature teratoma, a rare disease with complex treatment modalities.

Authors:  Cassandra Albertin; Karen A Johnson; Joseph P Connor; Ahmed N Al-Niaimi
Journal:  Gynecol Oncol Case Rep       Date:  2013-02-11

5.  Bilateral ovarian angiosarcoma arising from the mature cystic teratomas - A case report and review of the literature.

Authors:  Erik Kudela; Marcela Nachajova; Kamil Biringer; Pavol Slavik; Lukas Plank; Jan Danko
Journal:  Int J Surg Case Rep       Date:  2017-12-07

6.  Leiomyosarcoma and Squamous Cell Carcinoma Arising in Mature Cystic Teratoma of the Ovary.

Authors:  Tip Pongsuvareeyakul; Kornkanok Sukpan; Somjet Chaicharoen; Surapan Khunamornpong
Journal:  Case Rep Pathol       Date:  2017-07-02

7.  Immature ovarian teratoma with unusual gliomatosis.

Authors:  Ancuta Gheorghisan-Galateanu; Dana Cristina Terzea; Mara Carsote; Catalina Poiana
Journal:  J Ovarian Res       Date:  2013-04-16       Impact factor: 4.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.